Genetically Predicted Body Mass Index and Mortality in Chronic Obstructive Pulmonary Disease
- PMID: 38471013
- PMCID: PMC11506912
- DOI: 10.1164/rccm.202308-1384OC
Genetically Predicted Body Mass Index and Mortality in Chronic Obstructive Pulmonary Disease
Abstract
Rationale: Body mass index (BMI) is associated with chronic obstructive pulmonary disease (COPD) mortality, but the underlying mechanisms are unclear. The effect of genetic variants aggregated into a polygenic score may elucidate the causal mechanisms and predict risk. Objectives: To examine the associations of genetically predicted BMI with all-cause and cause-specific mortality in COPD. Methods: We developed a polygenic score (PGS) for BMI (PGSBMI) and tested for associations of the PGSBMI with all-cause, respiratory, and cardiovascular mortality in participants with COPD from the COPDGene (Genetic Epidemiology of COPD), ECLIPSE (Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points), and Framingham Heart studies. We calculated the difference between measured BMI and PGS-predicted BMI (BMIdiff) and categorized participants into groups of discordantly low (BMIdiff <20th percentile), concordant (BMIdiff between the 20th and 80th percentiles), and discordantly high (BMIdiff >80th percentile) BMI. We applied Cox models, examined potential nonlinear associations of the PGSBMI and BMIdiff with mortality, and summarized results with meta-analysis. Measurements and Main Results: We observed significant nonlinear associations of measured BMI and BMIdiff, but not PGSBMI, with all-cause mortality. In meta-analyses, a one-standard deviation increase in the PGSBMI was associated with an increased hazard for cardiovascular mortality (hazard ratio [HR], 1.29; 95% confidence interval [CI], 1.12-1.49), but not for respiratory or all-cause mortality. Compared with participants with concordant measured and genetically predicted BMI, those with discordantly low BMI had higher risks for all-cause mortality (HR, 1.57; 95% CI, 1.41-1.74) and respiratory death (HR, 2.01; 95% CI, 1.61-2.51). Conclusions: In people with COPD, a higher genetically predicted BMI is associated with higher cardiovascular mortality but not respiratory mortality. Individuals with a discordantly low BMI have higher all-cause and respiratory mortality rates than those with a concordant BMI.
Keywords: BMI; COPD; cardiovascular mortality; respiratory mortality; weight loss.
Comment in
-
Why Is Body Mass Index Related to Chronic Obstructive Pulmonary Disease? Is It All in the Genes?Am J Respir Crit Care Med. 2024 Oct 1;210(7):859-861. doi: 10.1164/rccm.202403-0601ED. Am J Respir Crit Care Med. 2024. PMID: 38593419 Free PMC article. No abstract available.
Similar articles
-
Self-management interventions for people with chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2022 Jan 10;1(1):CD002990. doi: 10.1002/14651858.CD002990.pub4. Cochrane Database Syst Rev. 2022. PMID: 35001366 Free PMC article.
-
Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2017 Aug 4;8(8):CD011682. doi: 10.1002/14651858.CD011682.pub2. Cochrane Database Syst Rev. 2017. PMID: 28777450 Free PMC article.
-
Nutritional supplementation for stable chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD000998. doi: 10.1002/14651858.CD000998.pub3. Cochrane Database Syst Rev. 2012. PMID: 23235577 Free PMC article.
-
Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2022 Nov 14;11(11):CD013343. doi: 10.1002/14651858.CD013343.pub2. Cochrane Database Syst Rev. 2022. PMID: 36373977 Free PMC article.
-
Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD).Cochrane Database Syst Rev. 2021 Jul 20;7(7):CD013196. doi: 10.1002/14651858.CD013196.pub2. Cochrane Database Syst Rev. 2021. PMID: 34693988 Free PMC article.
Cited by
-
Vaping causes an acute BMI-dependent change in pulmonary blood flow.Physiol Rep. 2024 Oct;12(20):e70094. doi: 10.14814/phy2.70094. Physiol Rep. 2024. PMID: 39424421 Free PMC article.
-
Why Is Body Mass Index Related to Chronic Obstructive Pulmonary Disease? Is It All in the Genes?Am J Respir Crit Care Med. 2024 Oct 1;210(7):859-861. doi: 10.1164/rccm.202403-0601ED. Am J Respir Crit Care Med. 2024. PMID: 38593419 Free PMC article. No abstract available.
-
Towards early detection and disease interception of COPD across the lifespan.Eur Respir Rev. 2025 Jul 9;34(177):240243. doi: 10.1183/16000617.0243-2024. Print 2025 Jul. Eur Respir Rev. 2025. PMID: 40633975 Free PMC article. Review.
-
Prolonged leisure time television watching as a risk factor for chronic obstructive pulmonary disease: Insights from Mendelian randomization.Medicine (Baltimore). 2025 Apr 18;104(16):e42142. doi: 10.1097/MD.0000000000042142. Medicine (Baltimore). 2025. PMID: 40258726 Free PMC article.
References
-
- Adeloye D, Song P, Zhu Y, Campbell H, Sheikh A, Rudan I, NIHR RESPIRE Global Respiratory Health Unit Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med . 2022;10:447–458. - PMC - PubMed
-
- Safiri S, Carson-Chahhoud K, Noori M, Nejadghaderi SA, Sullman MJM, Ahmadian Heris J, et al. Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990–2019: results from the Global Burden of Disease Study 2019. BMJ . 2022;378:e069679. - PMC - PubMed
-
- Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur Respir J . 2006;28:1245–1257. - PubMed
MeSH terms
Grants and funding
- R01 HL152728/HL/NHLBI NIH HHS/United States
- R01 HL153460/HL/NHLBI NIH HHS/United States
- R01 HL133135/HL/NHLBI NIH HHS/United States
- U01 HL089897/HL/NHLBI NIH HHS/United States
- R01 HL147148/HL/NHLBI NIH HHS/United States
- U01 HL089856/HL/NHLBI NIH HHS/United States
- R01 HL135142/HL/NHLBI NIH HHS/United States
- HHSN268201500001I/HL/NHLBI NIH HHS/United States
- K08HL159318/HL/NHLBI NIH HHS/United States
- 75N92019D00031/HL/NHLBI NIH HHS/United States
- P01 HL114501/HL/NHLBI NIH HHS/United States
- HHSN268201500001C/HL/NHLBI NIH HHS/United States
- Alpha-1 Foundation/United States
- N01 HC025195/HL/NHLBI NIH HHS/United States
- T32 HL105346/HL/NHLBI NIH HHS/United States
- K08 HL159318/HL/NHLBI NIH HHS/United States
- R01 HL137927/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical